Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer.
Majd IssaJoy TangYizhen GuoChris CossThomas A MaceJason BischofMitch PhelpsCarolyn J PresleyDwight H OwenPublished in: Expert review of anticancer therapy (2022)
In this review, we set out to describe the current state of research regarding potential risk factors for irAE in patients with non-small cell lung cancer, as well as explore the barriers to understanding irAE. We review data from irAE that occur in large phase 3 trials and prospective studies focusing on irAE, as well as the many retrospective studies that currently form the bulk of our understanding of irAE.